Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis ; volume:10 ; number:6 ; day:05 ; month:12 ; year:2008 ; pages:1-13 ; date:12.2008
Breast cancer research ; 10, Heft 6 (05.12.2008), 1-13, 12.2008
- Urheber
-
Lewis-Wambi, Joan S.
- Beteiligte Personen und Organisationen
-
Kim, Helen R.
Wambi, Chris
Patel, Roshani
Pyle, Jennifer R.
Klein-Szanto, Andres J.
Jordan, V. Craig
SpringerLink (Online service)
- DOI
-
10.1186/bcr2208
- URN
-
urn:nbn:de:1111-201603241874
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lewis-Wambi, Joan S.
- Kim, Helen R.
- Wambi, Chris
- Patel, Roshani
- Pyle, Jennifer R.
- Klein-Szanto, Andres J.
- Jordan, V. Craig
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α
Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis
Estrogen and breast cancer
Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue
Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α
Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis
Estrogen and breast cancer
Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue
Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α
Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis
Estrogen and breast cancer